<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font18 { font-size : 18; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font29">and </span>
   <span class="font21">with </span>
   <span class="font20">respiratory </span>
   <span class="font18">patients </span>
   <span class="font18">for </span>
   <span class="font15">influenza </span>
   <span class="font15">virus </span>
   <span class="font15">[]. </span>
   <span class="font15">are </span>
   <span class="font15">viruses </span>
   <span class="font14">infections </span>
   <span class="font13">viral </span>
   <span class="font13">been </span>
   <span class="font13">Infect </span>
   <span class="font13">may </span>
   <span class="font13">Dis </span>
   <span class="font13">pneumonia </span>
   <span class="font13">cell </span>
   <span class="font13">have </span>
   <span class="font13">infection </span>
   <span class="font12">human </span>
   <span class="font12">The </span>
   <span class="font12">common </span>
   <span class="font12">that </span>
   <span class="font12">from </span>
   <span class="font12">transplant </span>
   <span class="font12">after </span>
   <span class="font12">stem </span>
   <span class="font12">Marrow </span>
   <span class="font12">adenovirus </span>
   <span class="font12">studies </span>
   <span class="font12">{background </span>
   <span class="font11">Transplant </span>
   <span class="font11">detection </span>
   <span class="font11">not </span>
   <span class="font11">study </span>
   <span class="font11">these </span>
   <span class="font11">has </span>
   <span class="font11">marrow </span>
   <span class="font11">hematopoietic </span>
   <span class="font11">ribavirin </span>
   <span class="font11">syncytial </span>
   <span class="font11">therapy </span>
   <span class="font11">RSV </span>
   <span class="font11">also </span>
   <span class="font11">Clin </span>
   <span class="font11">PIV </span>
   <span class="font11">but </span>
   <span class="font11">margin </span>
   <span class="font11">treatment </span>
   <span class="font11">Microbiol </span>
   <span class="font11">only </span>
   <span class="font11">{border-style </span>
   <span class="font11">immunocompromised </span>
   <span class="font11">antiviral </span>
   <span class="font11">bone </span>
   <span class="font11">cause </span>
   <span class="font11">px;} </span>
   <span class="font11">was </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">most </span>
   <span class="font11">tract </span>
   <span class="font11">Med </span>
   <span class="font11">available </span>
   <span class="font11">disease </span>
   <span class="font11">mortality </span>
   <span class="font11">this </span>
   <span class="font11">assays </span>
   <span class="font11">lower </span>
   <span class="font11">severe </span>
   <span class="font10">clinical </span>
   <span class="font10">molecular </span>
   <span class="font10">new </span>
   <span class="font10">rates </span>
   <span class="font10">recipients </span>
   <span class="font10">shedding </span>
   <span class="font10">transplantation: </span>
   <span class="font10">HSCT </span>
   <span class="font10">However, </span>
   <span class="font10">PCR </span>
   <span class="font10">This </span>
   <span class="font10">[â€“]. </span>
   <span class="font10">about </span>
   <span class="font10">adult </span>
   <span class="font10">compared </span>
   <span class="font10">controlled </span>
   <span class="font10">evaluated </span>
   <span class="font10">manifestations </span>
   <span class="font10">than </span>
   <span class="font10">two </span>
   <span class="font10">using </span>
   <span class="font10">HM. </span>
   <span class="font10">Influenza </span>
   <span class="font10">URTI </span>
   <span class="font10">al.Respiratory </span>
   <span class="font10">allogeneic </span>
   <span class="font10">control </span>
   <span class="font10">immunocompetent </span>
   <span class="font10">randomised </span>
   <span class="font10">were </span>
   <span class="font10">among </span>
   <span class="font10">antigenic </span>
   <span class="font10">associated </span>
   <span class="font10">children </span>
   <span class="font10">high </span>
   <span class="font10">metapneumovirus </span>
   <span class="font10">more </span>
   <span class="font10">neuraminidase </span>
   <span class="font10">patients, </span>
   <span class="font10">rate </span>
   <span class="font10">rhinovirus </span>
   <span class="font10">specific </span>
   <span class="font10">which </span>
   <span class="font10">Common </span>
   <span class="font10">MPV </span>
   <span class="font10">These </span>
   <span class="font10">acute </span>
   <span class="font10">adenoviral </span>
   <span class="font10">can </span>
   <span class="font10">found </span>
   <span class="font10">infected </span>
   <span class="font10">nasopharyngeal </span>
   <span class="font10">suggested </span>
   <span class="font10">transplantation </span>
   <span class="font10">use </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">care </span>
   <span class="font10">diagnosis </span>
   <span class="font10">efficacy </span>
   <span class="font10">epidemiology </span>
   <span class="font10">following </span>
   <span class="font10">isolation </span>
   <span class="font10">multiplex </span>
   <span class="font10">must </span>
   <span class="font10">nosocomial </span>
   <span class="font10">parainfluenza </span>
   <span class="font10">patient </span>
   <span class="font10">patients. </span>
   <span class="font10">prospective </span>
   <span class="font10">related </span>
   <span class="font10">risk </span>
   <span class="font10">role </span>
   <span class="font10">vaccine </span>
   <span class="font10">Although </span>
   <span class="font10">Blood </span>
   <span class="font10">RNA </span>
   <span class="font10">RSV, </span>
   <span class="font10">activity </span>
   <span class="font10">adults </span>
   <span class="font10">based </span>
   <span class="font10">chronic </span>
   <span class="font10">cidofovir </span>
   <span class="font10">cohort </span>
   <span class="font10">data </span>
   <span class="font10">discovered </span>
   <span class="font10">intravenous </span>
   <span class="font10">one </span>
   <span class="font10">oseltamivir </span>
   <span class="font10">pediatric </span>
   <span class="font10">per </span>
   <span class="font10">prevent </span>
   <span class="font10">protein </span>
   <span class="font10">px; </span>
   <span class="font10">real-time </span>
   <span class="font10">reported </span>
   <span class="font10">responsible </span>
   <span class="font10">results </span>
   <span class="font10">viruses, </span>
   <span class="font10">viruses. </span>
   <span class="font10">within </span>
   <span class="font10">{font-family </span>
   <span class="font10">HM, </span>
   <span class="font10">PAChurchill </span>
   <span class="font10">Respiratory </span>
   <span class="font10">Virol </span>
   <span class="font10">acid </span>
   <span class="font10">adenoviruses </span>
   <span class="font10">al. </span>
   <span class="font10">al.Adenovirus </span>
   <span class="font10">al.Comparison </span>
   <span class="font10">amplification </span>
   <span class="font10">bacterial </span>
   <span class="font10">blood </span>
   <span class="font10">chiefly </span>
   <span class="font10">cohorts </span>
   <span class="font10">days </span>
   <span class="font10">described </span>
   <span class="font10">diagnostic </span>
   <span class="font10">diseasesPhiladelphia, </span>
   <span class="font10">drugs </span>
   <span class="font10">early </span>
   <span class="font10">exact </span>
   <span class="font10">font-size </span>
   <span class="font10">greater </span>
   <span class="font10">hospitalized </span>
   <span class="font10">incidence </span>
   <span class="font10">infections. </span>
   <span class="font10">infectious </span>
   <span class="font10">inhibitors </span>
   <span class="font10">introduced </span>
   <span class="font10">malignancies </span>
   <span class="font10">newly </span>
   <span class="font10">now </span>
   <span class="font10">nucleic </span>
   <span class="font10">number </span>
   <span class="font10">occur </span>
   <span class="font10">often </span>
   <span class="font10">other </span>
   <span class="font10">practice </span>
   <span class="font10">pre-emptive </span>
   <span class="font10">recent </span>
   <span class="font10">remains </span>
   <span class="font10">reports </span>
   <span class="font10">response </span>
   <span class="font10">result </span>
   <span class="font10">retrospective </span>
   <span class="font10">severity </span>
   <span class="font10">strains </span>
   <span class="font10">their </span>
   <span class="font10">transmission </span>
   <span class="font10">Engl </span>
   <span class="font10">Livingstone </span>
   <span class="font10">Neuraminidase </span>
   <span class="font10">aerosolized </span>
   <span class="font10">benefits </span>
   <span class="font10">better </span>
   <span class="font10">both </span>
   <span class="font10">cells </span>
   <span class="font10">clear </span>
   <span class="font10">contact </span>
   <span class="font10">critical </span>
   <span class="font10">detected </span>
   <span class="font10">double; </span>
   <span class="font10">due </span>
   <span class="font10">emergence </span>
   <span class="font10">evidence </span>
   <span class="font10">few </span>
   <span class="font10">fungal </span>
   <span class="font10">haematological </span>
   <span class="font10">identification </span>
   <span class="font10">inhibitor </span>
   <span class="font10">large </span>
   <span class="font10">mechanisms </span>
   <span class="font10">methods </span>
   <span class="font10">monoclonal </span>
   <span class="font10">needed </span>
   <span class="font10">occurrence </span>
   <span class="font10">outbreaks </span>
   <span class="font10">outcome </span>
   <span class="font10">pandemic </span>
   <span class="font10">preventing </span>
   <span class="font10">probably </span>
   <span class="font10">recently </span>
   <span class="font10">recipients: </span>
   <span class="font10">seems </span>
   <span class="font10">several </span>
   <span class="font10">should </span>
   <span class="font10">since </span>
   <span class="font10">small </span>
   <span class="font10">some </span>
   <span class="font10">swabs </span>
   <span class="font10">targets </span>
   <span class="font10">they </span>
   <span class="font10">those </span>
   <span class="font10">three </span>
   <span class="font10">upper </span>
   <span class="font10">variations </span>
   <span class="font10">via </span>
   <span class="font10">(Table </span>
   <span class="font10">Care </span>
   <span class="font10">Coronaviridae </span>
   <span class="font10">DNA </span>
   <span class="font10">Infection </span>
   <span class="font10">Infectious </span>
   <span class="font10">PIV, </span>
   <span class="font10">RSV-related </span>
   <span class="font10">Table </span>
   <span class="font10">They </span>
   <span class="font10">acquisition </span>
   <span class="font10">against </span>
   <span class="font10">and, </span>
   <span class="font10">assay </span>
   <span class="font10">before </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">causes </span>
   <span class="font10">chemotherapy </span>
   <span class="font10">conventional </span>
   <span class="font10">detect </span>
   <span class="font10">different </span>
   <span class="font10">disseminated </span>
   <span class="font10">during </span>
   <span class="font10">effect </span>
   <span class="font10">elderly </span>
   <span class="font10">factor </span>
   <span class="font10">factors </span>
   <span class="font10">fatal </span>
   <span class="font10">first </span>
   <span class="font10">given </span>
   <span class="font10">haematopoietic </span>
   <span class="font10">help </span>
   <span class="font10">hematologic </span>
   <span class="font10">host </span>
   <span class="font10">immunisation </span>
   <span class="font10">impact </span>
   <span class="font10">include </span>
   <span class="font10">influenza, </span>
   <span class="font10">influenza-related </span>
   <span class="font10">lead </span>
   <span class="font10">less </span>
   <span class="font10">level </span>
   <span class="font10">major </span>
   <span class="font10">measures </span>
   <span class="font10">outbreak </span>
   <span class="font10">pathogens </span>
   <span class="font10">progression </span>
   <span class="font10">prolonged </span>
   <span class="font10">protective </span>
   <span class="font10">rapid </span>
   <span class="font10">recipients, </span>
   <span class="font10">recognised </span>
   <span class="font10">recommended </span>
   <span class="font10">requires </span>
   <span class="font10">seasonal </span>
   <span class="font10">solid; </span>
   <span class="font10">supporting </span>
   <span class="font10">symptomatic </span>
   <span class="font10">transplantationBone </span>
   <span class="font10">trial </span>
   <span class="font10">trials </span>
   <span class="font10">viraemia </span>
   <span class="font10">weeks </span>
   <span class="font10">workers </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">.ChakrabartiSet </span>
   <span class="font10">.WhimbeyEet </span>
   <span class="font10">Adenoviruses </span>
   <span class="font10">Antigenic </span>
   <span class="font10">Cohort </span>
   <span class="font10">Diseases </span>
   <span class="font10">Early </span>
   <span class="font10">Euros </span>
   <span class="font10">Fig. </span>
   <span class="font10">Human </span>
   <span class="font10">Intravenous </span>
   <span class="font10">LRTI </span>
   <span class="font10">Most </span>
   <span class="font10">Multiplex </span>
   <span class="font10">Paramyxoviridae </span>
   <span class="font10">Picornaviridae </span>
   <span class="font10">Rev </span>
   <span class="font10">Two </span>
   <span class="font10">Viral </span>
   <span class="font10">Virus </span>
   <span class="font10">[], </span>
   <span class="font10">airflow </span>
   <span class="font10">al.A </span>
   <span class="font10">al.Influenza </span>
   <span class="font10">analysis </span>
   <span class="font10">antibodies </span>
   <span class="font10">autologous </span>
   <span class="font10">because </span>
   <span class="font10">believed </span>
   <span class="font10">belonging </span>
   <span class="font10">bold </span>
   <span class="font10">cases </span>
   <span class="font10">causative </span>
   <span class="font10">causing </span>
   <span class="font10">characteristics </span>
   <span class="font10">co-infections </span>
   <span class="font10">collection </span>
   <span class="font10">combined </span>
   <span class="font10">community </span>
   <span class="font10">community-acquired </span>
   <span class="font10">comparable </span>
   <span class="font10">considered </span>
   <span class="font10">coronavirus </span>
   <span class="font10">courier; </span>
   <span class="font10">drugs, </span>
   <span class="font10">duration </span>
   <span class="font10">effective </span>
   <span class="font10">em; </span>
   <span class="font10">enhance </span>
   <span class="font10">epidemiological </span>
   <span class="font10">extra-respiratory </span>
   <span class="font10">family </span>
   <span class="font10">flocked </span>
   <span class="font10">health </span>
   <span class="font10">high-risk </span>
   <span class="font10">higher </span>
   <span class="font10">hosts, </span>
   <span class="font10">humans </span>
   <span class="font10">immune </span>
   <span class="font10">immunity </span>
   <span class="font10">immunofluorescence </span>
   <span class="font10">immunoglobulins </span>
   <span class="font10">importance </span>
   <span class="font10">including </span>
   <span class="font10">increased </span>
   <span class="font10">individuals </span>
   <span class="font10">influenza: </span>
   <span class="font10">intensive </span>
   <span class="font10">isolated </span>
   <span class="font10">known </span>
   <span class="font10">lack </span>
   <span class="font10">lesser </span>
   <span class="font10">long </span>
   <span class="font10">many </span>
   <span class="font10">might </span>
   <span class="font10">monoplex </span>
   <span class="font10">numbers </span>
   <span class="font10">obstruction </span>
   <span class="font10">optimal </span>
   <span class="font10">out </span>
   <span class="font10">particularly </span>
   <span class="font10">pneumonia, </span>
   <span class="font10">possible </span>
   <span class="font10">precautions </span>
   <span class="font10">proven </span>
   <span class="font10">pt;} </span>
   <span class="font10">reaction </span>
   <span class="font10">recipientsBone </span>
   <span class="font10">recipientsClin </span>
   <span class="font10">resistant </span>
   <span class="font10">reverse </span>
   <span class="font10">samples </span>
   <span class="font10">screening </span>
   <span class="font10">sensitive </span>
   <span class="font10">serum </span>
   <span class="font10">similar </span>
   <span class="font10">single-stranded </span>
   <span class="font10">species </span>
   <span class="font10">studied </span>
   <span class="font10">surface </span>
   <span class="font10">test </span>
   <span class="font10">tests </span>
   <span class="font10">therapy, </span>
   <span class="font10">therefore </span>
   <span class="font10">treat </span>
   <span class="font10">true </span>
   <span class="font10">type </span>
   <span class="font10">types </span>
   <span class="font10">uncontrolled </span>
   <span class="font10">unknown. </span>
   <span class="font10">very </span>
   <span class="font10">â€“]. </span>
  </p>
 </body>
</html>
